A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer
Clinical trial NCT02000947 · COMPLETED
Trial details
- NCT number
- NCT02000947
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-25
- Primary completion
- 2019-09-17
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.